China First Domestic COVID-19 Antibody Therapy Moves Towards Green Light
Strong Overseas Efficacy Data
Brii’s antibody combo therapy nears approval in China, based on data from a late-stage study conducted outside the country.
Brii’s antibody combo therapy nears approval in China, based on data from a late-stage study conducted outside the country.